AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation-Reference-Cited by-同舟云学术

AXS-05: an investigational treatment for Alzheimer’s disease-associated agitation

Published:2022-07-06 Issue:8 Volume:31 Page:773-780
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ward Kristen¹,Citrome Leslie²

Affiliation:

1. Clinical Assistant Professor, Clinical Pharmacy Department, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA

2. Clinical Professor of Psychiatry & Behavioral Sciences, Department of Psychiatry and Behavioral Science, New York Medical College, Valhalla, NY, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2022.2096006

Reference74 articles.

1. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

2. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

3. Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

4. Neuropsychiatric Symptoms and Syndromes in a Large Cohort of Newly Diagnosed, Untreated Patients With Alzheimer Disease

5. Patient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pipelines for Alzheimer’s Disease Psychosis and Agitation;Chemical and Pharmaceutical Bulletin;2024-07-01

2. Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development;CNS Drugs;2024-06-27

3. Alzheimer's disease drug development pipeline: 2024;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-04

4. Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimer Disease;JAMA Neurology;2023-12-01

5. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets;Biomolecules;2022-11-11